Introduction
• Sepsis and meningitis in neonates and infants lead to substantial morbidity, mortality and economic loss
• Investment in optimal prevention and treatment strategies requires good estimates of their cost-effectiveness, which in turn requires understanding of the economic burden of disease
• We reviewed the global evidence on the acute costs of sepsis, meningitis and meningococcal septicaemia, among neonates and infants under 1 year • Costs inflated to 2017 and converted to US Dollars (USD)
Results
• 15 studies from high-income countries, 5 studies from middleincome countries and no studies from low-income settings Health care costs ranged from $55 to $129,632 for sepsis and $222 to $33,635 for meningitis but data are very limited in low-and middle-income countries.
